Next Article in Journal
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
Next Article in Special Issue
Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
Previous Article in Journal
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma
Previous Article in Special Issue
Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
 
 
Article

Article Versions Notes

Cancers 2019, 11(8), 1094; https://doi.org/10.3390/cancers11081094
Action Date Notes Link
article xml file uploaded 1 August 2019 14:19 CEST Original file -
article pdf uploaded. 1 August 2019 14:19 CEST Version of Record https://www.mdpi.com/2072-6694/11/8/1094/pdf-vor
article pdf uploaded. 6 August 2019 08:19 CEST Updated version of record https://www.mdpi.com/2072-6694/11/8/1094/pdf-vor
article xml file uploaded 12 August 2019 08:17 CEST Update -
article xml uploaded. 12 August 2019 08:17 CEST Update https://www.mdpi.com/2072-6694/11/8/1094/xml
article pdf uploaded. 12 August 2019 08:17 CEST Updated version of record https://www.mdpi.com/2072-6694/11/8/1094/pdf
article html file updated 12 August 2019 08:19 CEST Original file -
article html file updated 28 August 2019 04:49 CEST Update -
article html file updated 13 February 2020 06:42 CET Update -
article html file updated 20 July 2022 05:58 CEST Update https://www.mdpi.com/2072-6694/11/8/1094/html
Back to TopTop